Evidence map›Paper›PMID 35988549›Full record

SynthesisThe Lancet. Microbe2022

The association between early-life gut microbiota and childhood respiratory diseases: a systematic review.

Cristina Garcia-Maurino Alcazar, Veena Mazarello Paes, Yan Shao, Clarissa Oesser, Ada Miltz, Trevor D Lawley, Peter Brocklehurst, Alison Rodger, Nigel Field

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in The Lancet. Microbe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 5 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 5 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Global Microbiome: Core and Unique Signatures Across Diverse Populations.International journal of molecular sciences · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. The gut-lung axis in early life: microbiome-associated mechanisms and clinical relevance.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Cristina Garcia-Maurino AlcazarInstitute for Global Health, University College London, London, UK. Electronic address: cristina.alcazar.19@ucl.ac.uk.
Veena Mazarello PaesInstitute for Child Health, University College London, London, UK; John Radcliffe Hospital, University of Oxford, Oxford, UK.
Yan ShaoHost-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK.
Clarissa OesserInstitute for Global Health, University College London, London, UK.
Ada MiltzInstitute for Global Health, University College London, London, UK.
Trevor D LawleyHost-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK.
Peter BrocklehurstInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Alison RodgerInstitute for Global Health, University College London, London, UK; Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.
Nigel FieldInstitute for Global Health, University College London, London, UK.
University College London · GBWellcome Sanger Institute · GBJohn Radcliffe Hospital · GBRoyal Free London NHS Foundation Trust · GBUniversity of Birmingham · GB

Funding

Wellcome TrustWellcome Trust WT101169MA
6 · The paper itself

Abstract

Data from animal models suggest a role of early-life gut microbiota in lung immune development, and in establishing susceptibility to respiratory infections and asthma in humans. This systematic review summarises the association between infant (ages 0-12 months) gut microbiota composition measured by genomic sequencing, and childhood (ages 0-18 years) respiratory diseases (ie, respiratory infections, wheezing, or asthma). Overall, there was evidence that low α-diversity and relative abundance of particular gut-commensal bacteria genera (Bifidobacterium, Faecalibacterium, Ruminococcus, and Roseburia) are associated with childhood respiratory diseases. However, results were inconsistent and studies had important limitations, including insufficient characterisation of bacterial taxa to species level, heterogeneous outcome definitions, residual confounding, and small sample sizes. Large longitudinal studies with stool sampling during the first month of life and shotgun metagenomic approaches to improve bacterial and fungal taxa resolution are needed. Standardising follow-up times and respiratory disease definitions and optimising causal statistical approaches might identify targets for primary prevention of childhood respiratory diseases.

Indexed as

AsthmaGastrointestinal MicrobiomeRespiration DisordersRespiratory Tract InfectionsAdolescentBacteriaChildChild, PreschoolFecesHumansInfantInfant, NewbornRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID35988549
PMCPMC10499762
OpenAlexW4297924154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.